Member Info for shatter

Definitely a sounder looking company than a year ago. Nearly averaged down but glad I didn’t after the recent sp performance. Happy to hold in the meantime and see what the next few months bring.

And yes something needs to be done about the dismal share price but not sure what?

I never rated Peel Hunt but another broker might possibly be an indication of a listing across the water!

Positive news if a little scant on detail.

Just when the sp was starting to look a little healthier !

Not heavily invested here but the market does not seem overly impressed with the latest news. How much is the latest contract potentially worth? We can only guess! Will sit on my hands until some solid figures come in.

As you say still no figures mentioned. Would like to average down but want more detail re revenue or potential revenue. Volume is fairly low but it’s early days.

“potential future manufacturing opportunities for the AstraZeneca COVID-19 vaccine. “ Better than nothing..

Troy…Your analysis seems as good as any and as you say perhaps on the cautious side but until Sym give us a few more details doubling up would be very welcome.

Great news. Onwards and upwards…

Very good news and should help an already strong case with the EU. Court cases usually run over time so suspect the end of the year at the earliest. I hope Sym can make a sale or two on the strength of this case.

EU action

Symphony's legal team has received and reviewed the Defences served by the three Defendants (the Commission, the Parliament and the Council of the European Union ("EU")) to the action it has brought against them in the General Court of the EU. The action is in relation to their decision to adopt Article 5 of the Single Use Plastics Directive 2019/904 ("the Directive").

The Defences did not reveal anything unexpected, and Symphony's legal team remain confident that the EU acted unlawfully in imposing a ban on a material which they call "oxo-degradable plastic" in Article 5 of the Directive. In any event, Symphony does not accept that the ban applies to oxo-BIOdegradable plastics, which are made by incorporating Symphony's d2w masterbatch into ordinary plastic.

Symphony's legal team has accordingly filed Replies to each of the Defences, but a decision by the court is not expected for another 12-18 months.

Leak…we need the flood gates to open.

It might be that the vaccine news is already built into the share price now ! The markets and those in the know are bound to be fully aware that there will be no further revenues from Astra hence the massive drop and obvious concern re future costs and Homology.

Morning Kern
It has been remarkably quiet on the Oxb front as usual. No word on Homology progress but any rise is welcome. Would reinvest if I could be sure of hitting bottom but wouldn’t everyone. My technology and pharma funds ( in fact all my funds) are dropping like a stone and we aren’t officially in a recession yet.
Interesting and scary times ahead.

Who would have thought that the sp would have dropped 75% in less than 10 months! This can be a volatile share but where is the bottom?

Major shareholders don’t always get it right. Some have had quite a chequered past . Vulpes and the Diggles have had a few mishaps over the years. For the sp to drop by over two thirds is not a good investment no matter how you try to paint it. Diggle has stepped away as well.

Not sure we are ever going to see any measurable uplift in share price .Back in Sept 21 Symphony's CEO Michael Laurier said "We have been working for some time with customers in Canada, and approval from Health Canada now enables this project to proceed more quickly to commercialisation." I know we aren’t going to get a miracle but 10 months later, nothing! If this is such a great product surely there must be an update? Come on Sym get the finger out and replace the sales team if they aren’t performing.

I have three Baillie Gifford funds and would be better sticking the money on a horse with 3 legs.

Agree that this is a very frustrating share…facts and figures are always minimal and as for new contracts?
Been here for years with a higher average than I would like but have no reason to average down.